![](/img/cover-not-exists.png)
Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease
Fleseriu, Maria, Pivonello, Rosario, Young, Jacques, Hamrahian, Amir H., Molitch, Mark E., Shimizu, Chikara, Tanaka, Tomoaki, Shimatsu, Akira, White, Tracy, Hilliard, Annie, Tian, Chuan, Sauter, NichoVolume:
19
Language:
english
Journal:
Pituitary
DOI:
10.1007/s11102-015-0692-z
Date:
April, 2016
File:
PDF, 918 KB
english, 2016